Royal Bank of Canada
NBP

Royal Bank of Canada’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Royal Bank of Canada’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Sell
99
-6,261
-98% -$21K ﹤0.01% 7385
2025
Q4 		$25K Hold
6,360
– – ﹤0.01% 5919
2025
Q3 		$24K Buy
+6,360
New +$21.6K ﹤0.01% 6135
2024
Q3 		– Sell
-145
Closed – – 7108
2024
Q2 		$0 Sell
145
-1,499
-91% -$2.68K ﹤0.01% 7269
2024
Q1 		$3K Hold
1,644
– – ﹤0.01% 6595
2023
Q4 		$3K Sell
1,644
-1
-0.1% -$1 ﹤0.01% 6732
2023
Q3 		$2K Sell
1,645
-14
-0.8% -$31 ﹤0.01% 6794
2023
Q2 		$5K Buy
1,659
+12
+0.7% +$39 ﹤0.01% 6671
2023
Q1 		$6K Hold
1,647
– – ﹤0.01% 6509
2022
Q4 		$7K Buy
1,647
+17
+1% +$64 ﹤0.01% 6655
2022
Q3 		$7K Hold
1,630
– – ﹤0.01% 6594
2022
Q2 		$18K Sell
1,630
-187
-10% -$2.24K ﹤0.01% 6148
2022
Q1 		$29K Buy
1,817
+79
+5% +$2.02K ﹤0.01% 6401
2021
Q4 		$82K Sell
1,738
-35
-2% -$2.1K ﹤0.01% 6075
2021
Q3 		$128K Buy
1,773
+142
+9% +$10.3K ﹤0.01% 5535
2021
Q2 		$137K Buy
1,631
+1
+0.1% +$66 ﹤0.01% 5387
2021
Q1 		$79K Hold
1,630
– – ﹤0.01% 5610
2020
Q4 		$77K Hold
1,630
– – ﹤0.01% 5464
2020
Q3 		$77K Hold
1,630
– – ﹤0.01% 5121
2020
Q2 		$49K Buy
+1,630
New +$33.7K ﹤0.01% 5228

Other funds holding NBP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
ACM
AIHC Capital Management Central $120M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada's NBP Position: Q1 2026 in Review

Royal Bank of Canada reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 98% in Q1 2026, selling an estimated $21K and leaving 99 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7385.

Royal Bank of Canada first reported a position in NBP in Q2 2020 and has held it in 20 quarters since. The position peaked at $137K in Q2 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • Royal Bank of Canada held 99 shares of NovaBridge Biosciences American Depositary Shares worth $0 as of Q1 2026.
  • Royal Bank of Canada sold 6,261 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $21K.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7385 holding.
  • Royal Bank of Canada first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2020 and has held it in 20 quarters since.
  • Royal Bank of Canada's NovaBridge Biosciences American Depositary Shares position peaked at $137K in Q2 2021.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.